Alexander “Sasha” Gimelbrant is an Investigator at Altius Institute for Biomedical Sciences. He has earned his PhD in biochemistry at Moscow State University. After postdoctoral work at the Whitehead Institute and Massachusetts General Hospital, he started his laboratory at the Dana-Farber Cancer Institute. His lab is interested in the epigenetic mechanisms controlling allele-specific expression in development and disease, and the role of these mechanisms in biological variability.
]]>